(Reuters) - Medical device maker C.R. Bard Inc will pay about $48.3 million to resolve allegations it made illegal payments to hospitals and physicians to entice them to buy its radiation treatment for prostate cancer, the Justice Department said.... More »
MUMBAI (Reuters) - Ranbaxy Laboratories Ltd shares fell 3.4 percent in pre-open trading on Tuesday after the Indian generic drugmaker pleaded guilty to U.S. felony charges related to drug safety and will pay $500 million in civil and criminal fine... More »
(Reuters) - Amgen Inc has agreed to pay $24.9 million to settle allegations that it provided kickbacks to long-term care pharmacy providers to entice them to use its Aranesp anemia drug instead of a rival medicine, the Department of Justice announ... More »
LONDON (Reuters) - AstraZeneca has settled a legal fight over its top-selling cholesterol drug Crestor with generics companies, protecting revenues in the all-important U.S. market until 2016. Under the agreement, Watson and Egis concede that the ... More »